Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries GSK to pay up to $3.3 billion for biopharma Affinivax By: MarketWatch May 31, 2022 at 04:50 AM EDT GSK PLC said Tuesday that it has agreed to buy clinical-stage biopharmaceutical company Affinivax, Inc. for up to $3.3 billion. Read More >> Related Stocks: Gsk Plc ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
GSK to pay up to $3.3 billion for biopharma Affinivax By: MarketWatch May 31, 2022 at 04:50 AM EDT GSK PLC said Tuesday that it has agreed to buy clinical-stage biopharmaceutical company Affinivax, Inc. for up to $3.3 billion. Read More >> Related Stocks: Gsk Plc ADR